[논문]Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome

Olesen, Merete; Gudmand-Høyer, Eivind

doi:10.1093/ajcn/72.6.1570

[해외논문] Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome 원문보기

The American journal of clinical nutrition, v.72 no.6, 2000년, pp.1570 - 1575

Olesen, Merete , Gudmand-Høyer, Eivind

Abstract ▼ AI-Helper

BACKGROUND: Interest in fructooligosaccharides as a health-promoting food component is increasing. Fructooligosaccharides are mainly indigestible and large amounts in the colon may provoke gastrointestinal symptoms. OBJECTIVE: The symptoms of irritable bowel syndrome (IBS) may be provoked by large quantities of carbohydrates in the colon. The objective of this study was to determine whether regular consumption of fructooligosaccharides worsens gastrointestinal symptoms in patients with IBS. DESIGN: A multicenter, prospective, randomized, double-blind, placebo-controlled parallel group comparison was conducted at 24 sites. The study consisted of a 2-wk, single-blind run-in phase and a 12-wk, double-blind comparative phase. Subjects were randomly assigned to receive 20 g fructooligosaccharides powder/d (n = 52) or a placebo (n = 46). Efficacy was based on the patients' overall response to treatment at completion of the study and on the severity and duration of individual symptoms (abdominal distension, abdominal rumbling, abnormal flatulence, and abdominal pain). RESULTS: Data from 96 patients (16 men and 80 women) were analyzed. After 4-6 wk of treatment, IBS symptoms improved more in the placebo group than in the fructooligosaccharide group. After completion of the study, there were no significant differences between the 2 groups: symptoms improved in 58% of the fructooligosaccharide group and in 65% of the placebo group and symptoms worsened in 8% of the fructooligosaccharide group and in 13% of the placebo group. CONCLUSION: Although symptoms worsened in patients with IBS at the onset of treatment with 20 g fructooligosaccharides/d, continuous treatment for 12 wk resulted in no worsening of symptoms.

참고문헌 (25)

J Nutr Oku 114 1574 1984 10.1093/jn/114.9.1574 Nondigestibility of a new sweetener, “Neosugar,” in the rat

상세보기
Nutr Rev Oku 54 S59 1996 10.1111/j.1753-4887.1996.tb03820.x Oligosaccharides with beneficial health effects: a Japanese perspective

상세보기
Bifidobact Microflora Hidaka 5 37 1986 10.12938/bifidus1982.5.1_37 Effects of fructooligosaccharides on intestinal flora and human health

상세보기
Life Sci Delzenne 57 1579 1995 10.1016/0024-3205(95)02133-4 Effect of fermentable fructooligosaccharides on energy and micronutrients absorption in the rat

상세보기
Eur J Clin Nutr Coudray 51 375 1997 10.1038/sj.ejcn.1600417 Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men

상세보기
Am J Clin Nutr van den Heuvel 69 544 1999 10.1093/ajcn/69.3.544 Oligofructose stimulates calcium absorption in adolescents

상세보기
Br J Nutr Van Loo 81 121 1999 10.1017/S0007114599000252 Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095)

상세보기
J Nutr Gibson 125 1401 1995 10.1093/jn/125.6.1401 Dietary modulation of human colonic microbiota: introducing the concept of prebiotics

상세보기
1993 Gastrointestinal disease, pathophysiology, diagnosis/management.
Gut Thompson 45 suppl 1143 1999 Functional bowel disorders and functional abdominal pain
Gastroenterology Talley 101 927 1991 10.1016/0016-5085(91)90717-Y Epidemiology of colonic symptoms and the irritable bowel syndrome

상세보기
Gastroenterology Heaton 102 1962 1992 10.1016/0016-5085(92)90320-X Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters

상세보기
BMJ Jones 304 87 1992 10.1136/bmj.304.6819.87 Irritable bowel syndrome in the general population

상세보기
J Intern Med Kay 236 23 1994 10.1111/j.1365-2796.1994.tb01115.x The epidemiology of irritable bowel syndrome in a random population: prevalence, natural history and risk factors

상세보기
Br Med J Manning 2 653 1978 10.1136/bmj.2.6138.653 Towards a positive diagnosis of the irritable bowel syndrome
Am J Clin Nutr Stone-Dorshow 46 61 1987 10.1093/ajcn/46.1.61 Gaseous response to ingestion of poorly absorbed fructo-oligosaccharide sweetener

상세보기
Eur J Clin Nutr Briet 49 501 1995 Symptomatic response to varying levels of fructooligosaccharides consumed occasionally or regularly

상세보기
Gastroenterology Rumessen 95 694 1988 10.1016/S0016-5085(88)80016-7 Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures

상세보기
Am J Clin Nutr Teuri 69 973 1999 10.1093/ajcn/69.5.973 Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters

상세보기
Gastroenterology 112 2118 1997 10.1053/gast.1997.1122118 American Gastroenterological Association medical position statement: irritable bowel syndrome

상세보기
Br Med J Müeller-Leisner 296 615 1988 10.1136/bmj.296.6622.615 Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis

상세보기
Gastroenterology Klein 95 232 1988 10.1016/0016-5085(88)90319-8 Controlled treatment trials in the irritable bowel syndrome: a critique

상세보기
Lancet Francis 344 39 1994 10.1016/S0140-6736(94)91055-3 Bran and irritable bowel syndrome: time for reappraisal

상세보기
Am J Clin Nutr Flourié 58 369 1993 10.1093/ajcn/58.3.369 Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose?

상세보기
Am J Clin Nutr Hertzler 64 232 1996 10.1093/ajcn/64.2.232 Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance

상세보기

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

원문 보기

AccessON 원문보기

원문 URL 링크

DOI : 10.1093/ajcn/72.6.1570 [무료]
American Society for Nutrition : 저널
AccessON : 저널

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내

내보내기 메뉴

내보내기 구분

파일저장
인쇄
메일전송

구성항목

기본정보
상세정보

관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관

저장형식

Text(ASCII format)
Excel format
RefWorks Direct Export
RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley

메일정보

받는사람 (필수): @
보내는사람 (선택): @
제목
내용: KISTI 검색결과 이메일 서비스

안내

총 건의 자료가 검색되었습니다.

다운받으실 자료의 인덱스를 입력하세요. (1-10,000)

검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다.

데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요)

다운로드 파일은 UTF-8 형태로 저장됩니다.
파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오.

Text(ASCII format)
Excel format

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

연합인증